ãã€ãªå»è¬åäŒæ¥ã§ããNavidea Biopharmaceuticals, Inc.ã¯ã粟å¯å
ç«èšºæè¬ããã³å
ç«æ²»çè¬ã®éçºãšåååã«æ³šåããŠããŸããå瀟ã¯ã蚺æç©è³ªãšæ²»çéçºããã°ã©ã ã®2ã€ã®ã»ã°ã¡ã³ãã§äºæ¥ãå±éããŠããŸããå瀟ã¯ã掻æ§åãã¯ããã¡ãŒãžã«çºçŸããCD206ãã³ããŒã¹å容äœãæšçãšããããã»ãããã©ãããã©ãŒã ãéçºããŠããŸããCD206ãæšçãšããå瀟ã®è¬ç©ãã©ãããã©ãŒã ã¯ãåäžå
åæŸåºã³ã³ãã¥ãŒã¿ãŒæå±€æ®åœ±ãéœé»åæŸåºæå±€æ®åœ±ïŒPETïŒãã¬ã³ãã¹ãã£ã³ãè¡äžããã³/ãŸãã¯å
åŠèå
æ€åºããã¯ããã¡ãŒãžããã³å
ç«ããã³ççé¢é£çŸæ£ãæšçãšããæ²»çååç©ã®ééãªã©ãããŸããŸãªèšºææ§åŒã«é©çšã§ããŸããããã«ãå瀟ã¯ç¥çµãã¬ãŒãµãŒåè£è£œåã§ããNAV4694ããã³NAV5001ãæäŸããŠããŸããããã«ãTc99mãã«ããã»ãããªã©ã®èšºæç©è³ªããããã»ãããã©ãããã©ãŒã ã®ãã®ä»ã®èšºæçšéãéçºããŠããŸããããã³ããŸããŸãªæ²»çéçºããã°ã©ã ã«æºãã£ãŠããŸããå瀟ã¯ä»¥å㯠Neoprobe Corporation ãšããŠç¥ãããŠããŸãããã2012 幎 1 æã« Navidea Biopharmaceuticals, Inc. ã«ç€Ÿåã倿ŽããŸãããNavidea Biopharmaceuticals, Inc. 㯠1983 幎ã«èšç«ããããªãã€ãªå·ãããªã³ã«æ¬ç€Ÿã眮ããŠããŸãã